Sutro Biopharma Other Long Term Assets (Quarterly) Analysis

Sutro Biopharma, Inc. (STRO)

15.80 +0.88 (+5.90%) USD | NASDAQ | Jan 21, 16:00

15.92 +0.12 (+0.76%) After-Hours: 20:00

View Other Long Term Assets (Quarterly) for STRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

GT Biopharma, Inc.	--
Daré Bioscience, Inc.	Upgrade
Syndax Pharmaceuticals, Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade